A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects

Trial Profile

A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2016

At a glance

  • Drugs E 6011 (Primary)
  • Indications Crohn's disease; Inflammatory bowel diseases
  • Focus Adverse reactions; First in man
  • Sponsors Eisai Inc
  • Most Recent Events

    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 13 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
    • 06 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top